Amalgamated Financial Corp.
Follow13F filer, CIK 1823608, NEW YORK, NY
Amalgamated Financial Corp. reported $12,592,024,000 across 3,002 holdings for the quarter ended 2022-03-31, in a 13F-HR filed 2022-05-16. Its ten largest share positions make up 24.33% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001823608-22-000095
- Period
- 2022-03-31
- Reported value
- $12.6B
- Holdings
- 3,002
- Top 10 weight
- 24.33%
- New
- Sold out
Holdings, Q1 2022
Share positions as resolved from 13F-HR 0001823608-22-000095, largest first. % of portfolio is the value over $12,592,024,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| PREVAIL THERAPEUTICS INC CVRPREVAIL THERAPEUTICS INC CVR | 2,131 | $0 | 0% | Value filed as zero, left out of ratios. | |||
| DOVA PHARMACEUTICALS CVRDOVA PHARMACEUTICALS CVR | 1,568 | $0 | 0% | Value filed as zero, left out of ratios. |
How Q1 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001823608-22-000095 | base | 2022-05-16 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001823608-22-000095 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set |